交银医药创新股票A(004075)资产负债表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
资产 |
银行存款 |
- |
- |
- |
502,698,223.04 |
结算备付金 |
2,947,220.20 |
1,797,805.86 |
3,237,640.85 |
5,001,721.62 |
存出保证金 |
478,778.19 |
345,356.39 |
527,686.76 |
770,644.88 |
交易性金融资产 |
1,855,684,104.75 |
2,308,107,707.14 |
3,432,288,556.89 |
3,206,042,093.54 |
其中:股票投资 |
1,855,684,104.75 |
2,308,107,707.14 |
3,432,288,556.89 |
3,206,039,876.01 |
债券投资 |
- |
- |
- |
2,217.53 |
资产支持证券投资 |
- |
- |
- |
- |
衍生金融资产 |
- |
- |
- |
- |
买入返售金融资产 |
- |
- |
- |
- |
应收证券清算款 |
14,977,042.38 |
9,021,792.38 |
871,686.96 |
43,871,655.90 |
应收利息 |
- |
- |
- |
- |
应收股利 |
- |
- |
- |
- |
应收申购款 |
1,034,561.04 |
1,462,967.54 |
2,839,799.47 |
2,401,303.70 |
其他资产 |
- |
- |
- |
- |
资产总计 |
2,229,925,006.24 |
2,796,514,668.70 |
3,908,426,151.54 |
3,760,785,642.68 |
负 债 |
短期借款 |
- |
- |
- |
- |
交易性金融负债 |
- |
- |
- |
- |
衍生金融负债 |
- |
- |
- |
- |
卖出回购金融资产款 |
- |
- |
- |
- |
应付证券清算款 |
17,123,703.20 |
2,585,591.08 |
3,080,289.01 |
14,290,680.89 |
应付赎回款 |
5,512,518.81 |
3,446,466.39 |
22,709,168.81 |
6,179,416.97 |
应付管理人报酬 |
2,414,340.12 |
2,889,264.83 |
4,025,919.18 |
4,724,504.82 |
应付托管费 |
402,390.03 |
481,544.12 |
670,986.51 |
787,417.47 |
应付销售服务费 |
67,310.09 |
89,370.16 |
289,799.97 |
153,258.60 |
应付交易费用 |
- |
- |
- |
- |
应交税费 |
4.90 |
- |
- |
- |
应付利息 |
- |
- |
- |
- |
应付利润 |
- |
- |
- |
- |
其他负债 |
1,360,047.59 |
1,762,544.75 |
2,157,073.29 |
4,811,764.91 |
负债合计 |
26,880,314.74 |
11,254,781.33 |
32,933,236.77 |
30,947,043.66 |
所有者权益 |
实收基金 |
1,029,295,342.10 |
1,328,977,097.14 |
1,549,705,581.74 |
1,423,162,963.30 |
未分配利润 |
1,173,749,349.40 |
1,456,282,790.23 |
2,325,787,333.03 |
2,306,675,635.72 |
所有者权益合计 |
2,203,044,691.50 |
2,785,259,887.37 |
3,875,492,914.77 |
3,729,838,599.02 |
负债及所有者权益总计 |
2,229,925,006.24 |
2,796,514,668.70 |
3,908,426,151.54 |
3,760,785,642.68 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年